In addition, a recent meta-analysis has shown that the risk of post-colectomy infections is higher among patients who have pre-viously received treatment with infliximab OR 2.24 26.
De otra parte, el riesgo de infecciones postcolectomía es mayor en pacientes que han recibido previamente tratamiento con infliximab OR 2,24, como lo demuestra un reciente metanálisis 26.